Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic-Myeloproliferative Diseases × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 8 Brain Neoplasms 5 Neoplasm Metastasis 3 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurocytoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adamantinoma 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Busulfan 11 Mycophenolic Acid 10 Tacrolimus 9 Methotrexate 8 Cyclosporine 8 Antilymphocyte Serum 8 Etoposide 7 Melphalan 5 Cytarabine 5 Cyclosporins 5 Sirolimus 4 Radiotherapy 4 Rituximab 3 Filgrastim 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 ruxolitinib 2 Granulocyte Colony-Stimulating Factor 2 Flow Cytometry 2 Carmustine 2 Carboplatin 2 veliparib 1 vatalanib 1 treosulfan 1 sargramostim 1 rasburicase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡